Compounds > nky 722
Page last updated: 2024-09-05

nky 722 and potassium chloride

nky 722 has been researched along with potassium chloride in 4 studies

Compound Research Comparison

Studies
(nky 722)		Trials
(nky 722)		Recent Studies (post-2010)
(nky 722)		Studies
(potassium chloride)		Trials
(potassium chloride)		Recent Studies (post-2010) (potassium chloride)
120018,0403951,764

Protein Interaction Comparison

ProteinTaxonomynky 722 (IC50)potassium chloride (IC50)
Sodium/potassium/calcium exchanger 4Homo sapiens (human)174000
Sodium/potassium/calcium exchanger 2Homo sapiens (human)280000

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanda, M; Kurahashi, K; Osumi, S; Shimaji, H; Shirahase, H1
Fukata, F; Kanda, M; Kurahashi, K; Matsui, H; Nakamura, S; Shirahase, H; Wada, K1
Fukata, F; Kanda, M; Matsui, H; Morishita, S; Nakamura, S; Shirahase, H; Wada, K1
Fukata, F; Kanda, M; Matsui, H; Nakamura, S; Shirahase, H; Wada, K1

Other Studies

4 other study(ies) available for nky 722 and potassium chloride

ArticleYear
Effect of accumulation of NKY-722, a water-soluble vasoselective Ca++ antagonist, on KCl-induced contraction in isolated canine mesenteric arteries.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 258, Issue:2

    Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Dogs; Female; In Vitro Techniques; Male; Mesenteric Arteries; Potassium Chloride; Vasoconstriction

1991
Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
    Arzneimittel-Forschung, 1995, Volume: 45, Issue:8

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arteries; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Dihydropyridines; Dogs; Female; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nicardipine; Nifedipine; Norepinephrine; Potassium Chloride; Vasoconstrictor Agents; Vasodilator Agents

1995
Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats.
    Arzneimittel-Forschung, 1994, Volume: 44, Issue:10

    Topics: Anesthesia; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Heart Rate; Male; Nicardipine; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Wistar; Splanchnic Circulation

1994
Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the endothelium-independent and endothelium-dependent c
    Arzneimittel-Forschung, 1996, Volume: 46, Issue:7

    Topics: Acetylcholine; Adenosine Diphosphate; Animals; Calcium Channel Blockers; Cerebral Arteries; Dihydropyridines; Dogs; Endothelium, Vascular; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nicardipine; Potassium Chloride; Serotonin

1996